Net Margin - CG Oncology Inc (NASDAQ:CGON) - Alpha Spread
C

CG Oncology Inc
NASDAQ:CGON

Watchlist Manager
CG Oncology Inc
NASDAQ:CGON
Watchlist
Price: 39 USD -0.28% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
CG Oncology Inc?
Write Note

Net Margin
CG Oncology Inc

-12 278.7%
Current
-19 024%
Average
-7.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-12 278.7%
=
Net Income
-103.6m
/
Revenue
844k

Net Margin Across Competitors

Country US
Market Cap 2.6B USD
Net Margin
-12 279%
Country US
Market Cap 341.7B USD
Net Margin
10%
Country US
Market Cap 181.2B USD
Net Margin
10%
Country US
Market Cap 127.2B USD
Net Margin
32%
Country US
Market Cap 120B USD
Net Margin
-5%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country US
Market Cap 104.6B USD
Net Margin
4%
Country AU
Market Cap 141.9B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.1B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for CG Oncology Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-12 278.7%
=
Net Income
-103.6m
/
Revenue
844k
What is the Net Margin of CG Oncology Inc?

Based on CG Oncology Inc's most recent financial statements, the company has Net Margin of -12 278.7%.